• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷受体 A2B 负调控卵巢癌细胞的迁移。

Adenosine Receptor A2B Negatively Regulates Cell Migration in Ovarian Carcinoma Cells.

机构信息

Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Campus UNAM-Juriquilla, Querétaro 76230, CP, Mexico.

出版信息

Int J Mol Sci. 2022 Apr 21;23(9):4585. doi: 10.3390/ijms23094585.

DOI:10.3390/ijms23094585
PMID:35562985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9100769/
Abstract

The purinergic system is fundamental in the tumor microenvironment, since it regulates tumor cell interactions with the immune system, as well as growth and differentiation in autocrine-paracrine responses. Here, we investigated the role of the adenosine A2B receptor (A2BR) in ovarian carcinoma-derived cells' (OCDC) properties. From public databases, we documented that high A2BR expression is associated with a better prognostic outcome in ovarian cancer patients. In vitro experiments were performed on SKOV-3 cell line to understand how A2BR regulates the carcinoma cell phenotype associated with cell migration. RT-PCR and Western blotting revealed that the transcript (coding for A2BR) and A2BR were expressed in SKOV-3 cells. Stimulation with BAY-606583, an A2BR agonist, induced ERK1/2 phosphorylation, which was abolished by the antagonist PSB-603. Pharmacological activation of A2BR reduced cell migration and actin stress fibers; in agreement, A2BR knockdown increased migration and enhanced actin stress fiber expression. Furthermore, the expression of E-cadherin, an epithelial marker, increased in BAY-606583-treated cells. Finally, cDNA microarrays revealed the pathways mediating the effects of A2BR activation on SKOV-3 cells. Our results showed that A2BR contributed to maintaining an epithelial-like phenotype in OCDC and highlighted this purinergic receptor as a potential biomarker.

摘要

嘌呤能系统在肿瘤微环境中起着基础性作用,因为它调节肿瘤细胞与免疫系统的相互作用,以及自分泌-旁分泌反应中的生长和分化。在这里,我们研究了腺苷 A2B 受体 (A2BR) 在卵巢癌细胞源性细胞 (OCDC) 特性中的作用。从公共数据库中,我们记录到 A2BR 高表达与卵巢癌患者的预后更好相关。在 SKOV-3 细胞系上进行的体外实验,旨在了解 A2BR 如何调节与细胞迁移相关的癌性细胞表型。RT-PCR 和 Western blot 显示 SKOV-3 细胞中表达 转录本(编码 A2BR)和 A2BR。用 A2BR 激动剂 BAY-606583 刺激诱导 ERK1/2 磷酸化,该磷酸化被拮抗剂 PSB-603 所阻断。A2BR 的药理学激活减少了细胞迁移和肌动蛋白应力纤维;与之一致,A2BR 的敲低增加了迁移并增强了肌动蛋白应力纤维的表达。此外,上皮标志物 E-钙黏蛋白的表达在 BAY-606583 处理的细胞中增加。最后,cDNA 微阵列揭示了介导 A2BR 激活对 SKOV-3 细胞影响的途径。我们的结果表明,A2BR 有助于维持 OCDC 中的上皮样表型,并突出了该嘌呤能受体作为潜在的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/e266d8320800/ijms-23-04585-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/a9f2a21a67c2/ijms-23-04585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/dab110255b93/ijms-23-04585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/cc7f93dc97d1/ijms-23-04585-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/f77abdd29659/ijms-23-04585-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/fdb2831a5126/ijms-23-04585-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/c62d018f57b2/ijms-23-04585-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/e266d8320800/ijms-23-04585-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/a9f2a21a67c2/ijms-23-04585-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/dab110255b93/ijms-23-04585-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/cc7f93dc97d1/ijms-23-04585-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/f77abdd29659/ijms-23-04585-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/fdb2831a5126/ijms-23-04585-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/c62d018f57b2/ijms-23-04585-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0f/9100769/e266d8320800/ijms-23-04585-g007.jpg

相似文献

1
Adenosine Receptor A2B Negatively Regulates Cell Migration in Ovarian Carcinoma Cells.腺苷受体 A2B 负调控卵巢癌细胞的迁移。
Int J Mol Sci. 2022 Apr 21;23(9):4585. doi: 10.3390/ijms23094585.
2
The adenosine A2b receptor promotes tumor progression of bladder urothelial carcinoma by enhancing MAPK signaling pathway.腺苷A2b受体通过增强丝裂原活化蛋白激酶(MAPK)信号通路促进膀胱尿路上皮癌的肿瘤进展。
Oncotarget. 2017 Jul 25;8(30):48755-48768. doi: 10.18632/oncotarget.17835.
3
Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.B16黑色素瘤中A2B腺苷受体的激活诱导FAP阳性肿瘤基质细胞中CXCL12的表达,促进肿瘤进展。
Oncotarget. 2016 Sep 27;7(39):64274-64288. doi: 10.18632/oncotarget.11729.
4
The Expression of Adenosine A2B Receptor on Antigen-Presenting Cells Suppresses CD8 T-cell Responses and Promotes Tumor Growth.抗原呈递细胞上腺苷A2B受体的表达抑制CD8 T细胞反应并促进肿瘤生长。
Cancer Immunol Res. 2020 Aug;8(8):1064-1074. doi: 10.1158/2326-6066.CIR-19-0833. Epub 2020 May 7.
5
Chemotherapy-induced adenosine A2B receptor expression mediates epigenetic regulation of pluripotency factors and promotes breast cancer stemness.化疗诱导的腺苷 A2B 受体表达介导多能性因子的表观遗传调控,促进乳腺癌干细胞特性。
Theranostics. 2022 Feb 28;12(6):2598-2612. doi: 10.7150/thno.70581. eCollection 2022.
6
Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma.在黑色素瘤小鼠模型中,阻断A2b腺苷受体可减少骨髓来源的抑制性细胞介导的肿瘤生长和免疫抑制。
Neoplasia. 2013 Dec;15(12):1400-9. doi: 10.1593/neo.131748.
7
Blockade of Adenosine A2b Receptor Reduces Tumor Growth and Migration in Renal Cell Carcinoma.腺苷 A2b 受体阻断可减少肾细胞癌的肿瘤生长和迁移。
J Cancer. 2020 Jan 1;11(2):421-431. doi: 10.7150/jca.31245. eCollection 2020.
8
TNF-alpha upregulates adenosine 2b (A2b) receptor expression and signaling in intestinal epithelial cells: a basis for A2bR overexpression in colitis.肿瘤坏死因子-α上调肠上皮细胞中腺苷2b(A2b)受体的表达及信号传导:结肠炎中A2bR过表达的一个基础。
Cell Mol Life Sci. 2005 Nov;62(22):2647-57. doi: 10.1007/s00018-005-5328-4.
9
AR-dependent signaling alters immune cell composition and enhances IL-6 formation in the ischemic heart.AR 依赖性信号转导改变了缺血性心脏中的免疫细胞组成,并增强了 IL-6 的形成。
Am J Physiol Heart Circ Physiol. 2019 Jul 1;317(1):H190-H200. doi: 10.1152/ajpheart.00029.2019. Epub 2019 May 3.
10
A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice.A2B腺苷受体阻断增强巨噬细胞介导的细菌吞噬作用并改善小鼠多微生物败血症的存活率。
J Immunol. 2011 Feb 15;186(4):2444-53. doi: 10.4049/jimmunol.1001567. Epub 2011 Jan 17.

引用本文的文献

1
Novel therapeutic strategies for non-small cell lung cancer: Combination therapies with immune checkpoint inhibitors (Review).非小细胞肺癌的新型治疗策略:免疫检查点抑制剂联合疗法(综述)
Oncol Lett. 2025 Jul 3;30(3):424. doi: 10.3892/ol.2025.15170. eCollection 2025 Sep.
2
To verify the biological characteristics of disulfidptosis associated gene ADORA2B in esophageal cancer.验证食管癌中与二硫键连接的细胞程序性坏死相关基因ADORA2B的生物学特性。
BMC Gastroenterol. 2025 May 19;25(1):382. doi: 10.1186/s12876-025-03768-4.
3
A novel L-shaped ortho-quinone analog targeting adenosine A2b receptor to inhibit epithelial-mesenchymal transition in colorectal cancer cells.

本文引用的文献

1
MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma.MMP1 和 MMP9 是葡萄膜黑色素瘤有潜力的预后生物标志物和治疗靶点。
BMC Cancer. 2021 Sep 29;21(1):1068. doi: 10.1186/s12885-021-08788-3.
2
Adenosine/TGFβ axis in regulation of mammary fibroblast functions.腺苷/TGFβ 轴在调节乳腺成纤维细胞功能中的作用。
PLoS One. 2021 Jun 8;16(6):e0252424. doi: 10.1371/journal.pone.0252424. eCollection 2021.
3
Regulation of ZMYND8 to Treat Cancer.ZMYND8 的调控与癌症治疗。
一种新型L形邻醌类似物,靶向腺苷A2b受体以抑制结肠癌细胞的上皮-间质转化。
Med Oncol. 2025 May 5;42(6):197. doi: 10.1007/s12032-025-02767-5.
4
Radioresistance-related gene signatures identified by transcriptomics characterize the prognosis and immune landscape of pancreatic cancer patients.通过转录组学鉴定的放射抗性相关基因特征可表征胰腺癌患者的预后和免疫格局。
BMC Cancer. 2024 Dec 5;24(1):1497. doi: 10.1186/s12885-024-13231-4.
5
Extracellular ATP/P2X7 receptor, a regulatory axis of migration in ovarian carcinoma-derived cells.细胞外ATP/P2X7受体,卵巢癌细胞迁移的调控轴。
PLoS One. 2024 Jun 13;19(6):e0304062. doi: 10.1371/journal.pone.0304062. eCollection 2024.
6
Purinergic Signalling in Physiology and Pathophysiology.嘌呤能信号转导在生理学和病理生理学中的作用
Int J Mol Sci. 2023 May 24;24(11):9196. doi: 10.3390/ijms24119196.
7
The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer.胰腺癌中 Adora2b 受体作为免疫治疗靶点的复兴。
Front Immunol. 2023 Apr 28;14:1163585. doi: 10.3389/fimmu.2023.1163585. eCollection 2023.
8
Adenosine Receptor A2B Antagonist Inhibits the Metastasis of Gastric Cancer Cells and Enhances the Efficacy of Cisplatin.腺嘌呤受体 A2B 拮抗剂抑制胃癌细胞转移并增强顺铂疗效。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338221150318. doi: 10.1177/15330338221150318.
9
Targeting purine metabolism in ovarian cancer.靶向卵巢癌中的嘌呤代谢。
J Ovarian Res. 2022 Aug 13;15(1):93. doi: 10.1186/s13048-022-01022-z.
Molecules. 2021 Feb 18;26(4):1083. doi: 10.3390/molecules26041083.
4
Berberine inhibited metastasis through miR-145/MMP16 axis in vitro.小檗碱通过 miR-145/MMP16 轴在体外抑制转移。
J Ovarian Res. 2021 Jan 6;14(1):4. doi: 10.1186/s13048-020-00752-2.
5
Targeting Tumor-derived Exosomes Expressing CD73: New Opportunities in the Pathogenesis and Treatment of Cancer.靶向表达CD73的肿瘤源性外泌体:癌症发病机制与治疗的新机遇
Curr Mol Med. 2021;21(6):476-483. doi: 10.2174/1566524020666201120142953.
6
Adenosine Signaling in the Tumor Microenvironment.肿瘤微环境中的腺苷信号传导。
Adv Exp Med Biol. 2021;1270:145-167. doi: 10.1007/978-3-030-47189-7_9.
7
miR-371b-5p promotes cell proliferation, migration and invasion in non-small cell lung cancer via SCAI.miR-371b-5p 通过 SCAI 促进非小细胞肺癌细胞的增殖、迁移和侵袭。
Biosci Rep. 2020 Nov 27;40(11). doi: 10.1042/BSR20200163.
8
Lipocalin2 promotes cell proliferation and migration in ovarian cancer through activation of the ERK/GSK3β/β-catenin signaling pathway.脂联素 2 通过激活 ERK/GSK3β/β-连环蛋白信号通路促进卵巢癌细胞增殖和迁移。
Life Sci. 2020 Dec 1;262:118492. doi: 10.1016/j.lfs.2020.118492. Epub 2020 Sep 25.
9
Purinergic Signaling in the Hallmarks of Cancer.嘌呤能信号在癌症特征中的作用。
Cells. 2020 Jul 3;9(7):1612. doi: 10.3390/cells9071612.
10
Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles.上皮性卵巢癌转移的当前见解——希望与障碍
Cell Oncol (Dordr). 2020 Aug;43(4):515-538. doi: 10.1007/s13402-020-00513-9. Epub 2020 May 16.